WIN-Partners CoTSE:3183 +0.31%63 Gross Margin % is 11.84% as of Mar. 2026, which is 5% below its 10-year median of 12.42. GuruFocus rates TSE:3183 with a GF Score™ of 63/100 and a GF Value™ of 円1,522.55 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 116 Medical Distribution companies, WIN-Partners Co ranks worse than 59.48% on this metric.
WIN-Partners Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.2%.
The historical rank and industry rank for WIN-Partners Co's Gross Margin % or its related term are showing as below:
TSE:3183'
s Gross Margin % Range Over the Past 10 Years
Min: 11.79 Med: 12.42 Max: 13.07
Current: 11.8
During the past 13 years, the highestGross Margin % of WIN-Partners Co was 13.07%. The lowest was 11.79%. And the median was 12.42%.
TSE:3183's Gross Margin % is ranked worse than 59.48% of 116
companies
in the Medical Distribution industry
Industry Median: 14.9
vs TSE:3183: 11.80
WIN-Partners Co had a gross margin of 11.84% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for WIN-Partners Co was -1.20% per year.
WIN-Partners Co (TSE:3183) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
WIN-Partners Co had a gross margin of 11.84% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
WIN-Partners Co Gross Margin % Related Terms
WIN-Partners Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for WIN-Partners Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3183 vs MCK, CAH, COR: Gross Margin % Comparison
For the Medical Distribution subindustry, WIN-Partners Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WIN-Partners Co Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where WIN-Partners Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
WIN-Partners Co (TSE:3183) has a Gross Margin % of 11.84% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on WIN-Partners Co and its competitors. This is near median its historical median of 12.42. Over the past decade, WIN-Partners Co's Gross Margin % has ranged from 11.79 to 13.07. According to the industry distribution chart, WIN-Partners Co ranks #69 out of 116 companies in the Medical Distribution industry, placing it in the top 59.5%.
Is WIN-Partners Co's Gross Margin % too high?
WIN-Partners Co's current Gross Margin % of 11.84% is near median its 10-year median of 12.42. Over the past 10 years, this metric has ranged from a low of 11.79 to a high of 13.07. The Medical Distribution industry median Gross Margin % is 14.90. WIN-Partners Co's value of 11.84% is 20.5% below this industry median. Based on the distribution chart, WIN-Partners Co ranks #69 out of 116 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, WIN-Partners Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WIN-Partners Co's Gross Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, WIN-Partners Co ranks #69 out of 116 companies for Gross Margin %. This places WIN-Partners Co in the lower half of its industry. The industry median Gross Margin % is 14.90. WIN-Partners Co's value of 11.84% is 20.5% below this benchmark. Historically, WIN-Partners Co's own Gross Margin % has ranged from 11.79 to 13.07 over the past decade. While the company's 10-year median is 12.42 vs. the industry median of 14.90, WIN-Partners Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 14.90, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WIN-Partners Co's current Gross Margin % of 11.84% is 20.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on WIN-Partners Co and its competitors. For the Medical Distribution industry, the median Gross Margin % is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WIN-Partners Co's current Gross Margin % is 11.84%, which is near median its own 10-year median of 12.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WIN-Partners Co stock overvalued right now?
Based on GuruFocus' analysis, WIN-Partners Co (TSE:3183) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,522.55, compared to a current price of 円1,285.00 — trading 15.6% below its estimated fair value. The current Gross Margin % is 11.84%, which is near median its 10-year median of 12.42 and 20.5% below the Medical Distribution industry median of 14.90. WIN-Partners Co's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For WIN-Partners Co (TSE:3183), the current Gross Margin % is 11.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WIN-Partners Co (TSE:3183) Overvalued in 2026?
Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued.
The current stock price of 円1,285.00 is trading 15.6% below its estimated GF Value™ of 円1,522.55.
GuruFocus considers WIN-Partners Co to be Modestly Undervalued.
Key valuation signals for TSE:3183:
Gross Margin %: 11.84% (near median its 10-year median of 12.42)
GF Value™: 円1,522.55 vs. price of 円1,285.00 (15.6% below fair value)
Industry Position: 20.5% below the Medical Distribution median (#69 of 116)
No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
63GF Score
Get the complete analysis for TSE:3183
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3183 has been successfully added to your 
